Improving Access to Biomarker Testing in Medicaid Populations

Key Activities

2022 study: Medicaid beneficiaries 19% less likely to undergo testing; 27% higher mortality risk vs. commercially insured. Joint educational initiative producing evidence base; findings informing Medicaid advocacy and programming.

Dates

2022 – Ongoing